Register Now

Sun Pharma Q2 profit beats estimates on strong India demand

Sun Pharma beat profit forecasts on strong India demand and plans to enter the weight-loss drug market once semaglutide patents expire in 2026.

Leave a Reply

Your email address will not be published. Required fields are marked *